{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:59:07Z","timestamp":1790888347260,"version":"4.1.0"},"reference-count":14,"publisher":"Wiley","issue":"15","license":[{"start":{"date-parts":[[2017,3,26]],"date-time":"2017-03-26T00:00:00Z","timestamp":1490486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,3,26]],"date-time":"2017-03-26T00:00:00Z","timestamp":1490486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["P50AG05138"],"award-info":[{"award-number":["P50AG05138"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Statist. Med."],"published-print":{"date-parts":[[2017,7,10]]},"DOI":"10.1002\/sim.7284","type":"journal-article","created":{"date-parts":[[2017,3,26]],"date-time":"2017-03-26T23:36:39Z","timestamp":1490571399000},"page":"2452-2465","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Weighted win loss approach for analyzing prioritized outcomes"],"prefix":"10.1002","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8214-9874","authenticated-orcid":false,"given":"Xiaodong","family":"Luo","sequence":"first","affiliation":[{"name":"Research and Development; Sanofi US; Bridgewater 08807 NJ U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Division of Biometrics I, Office of Biostatistics; Center for Drug Evaluation and Research, US Food and Drug Administration; Silver Spring MD 20993 U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bai","sequence":"additional","affiliation":[{"name":"Division of Biometrics I, Office of Biostatistics; Center for Drug Evaluation and Research, US Food and Drug Administration; Silver Spring MD 20993 U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tian","sequence":"additional","affiliation":[{"name":"Janssen Research and Development; Raritan NJ 08869 U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,26]]},"reference":[{"key":"10.1002\/sim.7284-BIB0001|sim7284-cit-0001","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/sim.3923","article-title":"Generalized pairwise comparisons of prioritized outcomes in the two-sample problem","volume":"29","author":"Buyse","year":"2010","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/sim.7284-BIB0002|sim7284-cit-0002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/sim.7284-BIB0003|sim7284-cit-0003","first-page":"11","article-title":"Re-thinking composite endpoints in clinical trials: insights from patients and trialists","volume":"134","author":"Stolker","year":"2014","journal-title":"Circulation"},{"key":"10.1002\/sim.7284-BIB0004|sim7284-cit-0004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/pst.1743","article-title":"A win ratio approach to comparing continuous non-normal outcomes in clinical trials","volume":"15","author":"Wang","year":"2016","journal-title":"Pharmaceutical Statistics"},{"key":"10.1002\/sim.7284-BIB0005|sim7284-cit-0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cct.2016.04.001","article-title":"The win ratio approach to analyzing composite outcomes: an application to the EVOLVE trial","volume":"48","author":"Abdalla","year":"2016","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/sim.7284-BIB0006|sim7284-cit-0006","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/biom.12225","article-title":"An alternative approach to confidence interval estimation for the win ratio statistic","volume":"71","author":"Luo","year":"2015","journal-title":"Biometrics"},{"key":"10.1002\/sim.7284-BIB0007|sim7284-cit-0007","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/biostatistics\/kxv032","article-title":"Large sample inference for a win ratio analysis of a composite outcome based on prioritized components","volume":"17","author":"Bebu","year":"2016","journal-title":"Biostatistics"},{"key":"10.1002\/sim.7284-BIB0008|sim7284-cit-0008","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/biomet\/asw026","article-title":"On the win-ratio statistic in clinical trials with multiple types of event","volume":"103","author":"Oakes","year":"2016","journal-title":"Biometrika"},{"key":"10.1002\/sim.7284-BIB0009|sim7284-cit-0009","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/03610928108828073","article-title":"A class of hypothesis tests for one and two samples censored survival data","volume":"10","author":"Fleming","year":"1981","journal-title":"Communications in Statistics"},{"key":"10.1002\/sim.7284-BIB0010|sim7284-cit-0010","volume-title":"High Dimensional Probability II. Progress in Probability","author":"Gin\u00e9","year":"2000"},{"key":"10.1002\/sim.7284-BIB0011|sim7284-cit-0011","volume-title":"Progress in Probability of Stochastic Inequalities and Applications","volume":"56","author":"Reynaud-Bouret","year":"2003"},{"key":"10.1002\/sim.7284-BIB0012|sim7284-cit-0012","volume-title":"R: A Language and Environment for Statistical Computing","author":"R\u00a0Development\u00a0Core\u00a0Team","year":"2011"},{"key":"10.1002\/sim.7284-BIB0013|sim7284-cit-0013","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"The\u00a0PEACE\u00a0Trial\u00a0Investigators","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/sim.7284-BIB0014|sim7284-cit-0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"New England Journal of Medicine"}],"container-title":["Statistics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fsim.7284","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/sim.7284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T07:07:23Z","timestamp":1625382443000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/sim.7284"}},"subtitle":["X. LUO<i>et al.<\/i>"],"short-title":[],"issued":{"date-parts":[[2017,3,26]]},"references-count":14,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,7,10]]}},"URL":"https:\/\/doi.org\/10.1002\/sim.7284","archive":["Portico"],"relation":{},"ISSN":["0277-6715"],"issn-type":[{"value":"0277-6715","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,26]]}}}